Skip to main content
NIH funding notice RFA-DA-22-017

PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)

Closed on November 12, 2021.

Posted
June 16, 2021
Close date
November 12, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,452,950 in first-year total cost, median $726,475.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 LXF-C (13)]2

Most frequent institutions

  1. FRIENDS RESEARCH INSTITUTE, INC.1
  2. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
Competing awards under RFA-DA-22-017 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022SAIA-PrEP: a systems analysis and improvement approach to optimize PrEP implementation in syringe service programs1R01DA056883-01BAZZI, ANGELA ROBERTSONLAMBDIN, BARROT HOPKINSROTH, ALEXIS MARIEUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$858,690ZDA1
2022Optimizing PrEP Implementation and Cost-effectiveness among Sexual and Gender Minority Individuals with a Substance Use Disorder1R01DA056888-01MURPHY, SEAN M.REBACK, CATHY JFRIENDS RESEARCH INSTITUTE, INC., MD$594,260ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-22-017: PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) | ScienceDex | ConductScience